Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in LNTH — Lantheus Holdings, Inc.

CIK 861177 NEW YORK, NY

Position in LNTH

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$36,900,870
+$3,634,325 QoQ
Shares Held
486,498
-2.7% QoQ
Ownership
0.747%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 43.28938659562835.ToString("F0")% Shared 0.ToString("F0")% None 56.71061340437166.ToString("F0")%

Common Shares in LNTH Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $926,551,772 across 34 Drug Manufacturers - Specialty & Generic names. LNTH ranks #5 (4.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 LNTH
Lantheus Holdings, Inc.
This page
486,498 $36,900,870

All Filings in LNTH

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $36,900,870 486,498
2025-12-31 $33,266,545 499,873
2025-09-30 $23,001,101 448,452
2025-06-30 $21,172,103 258,638
2025-03-31 $17,857,577 182,967
2024-12-31 $17,150,014 191,706
2024-09-30 $15,225,724 138,731
2024-06-30 $12,416,684 154,648
2024-03-31 $5,078,035 81,588
2023-12-31 $5,058,456 81,588
2023-09-30 $5,621,069 80,902
2023-06-30 $6,882,528 82,013
2023-03-31 $6,770,990 82,013
2022-12-31 $3,895,431 76,441
2022-09-30 $5,140,770 73,095
2022-06-30 $5,786,272 87,631
2022-03-31 $3,566,165 64,476
2021-12-31 $1,656,579 57,341
2021-09-30 $1,472,515 57,341
2021-06-30 $1,584,902 57,341
2021-03-31 $1,128,506 52,808
2020-12-31 $592,723 43,938
2020-09-30 $556,693 43,938
2020-06-30 $769,681 53,824
2020-03-31 $516,574 40,484